News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
GREAT POINT PARTNERS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/16/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7.6% stake in ZURA BIO LIMITED |
| 04/13/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.4% stake in HERON THERAPEUTICS, INC. |
| 02/27/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7.3% stake in Precision BioSciences Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2022 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.2% stake in Kalvista Pharmaceuticals, Inc. |
| 03/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/07/2020 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 10% stake in Abeona Therapeutics Inc. |
| 06/05/2020 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.5% stake in Constellation Pharmaceuticals, Inc. |
| 06/01/2020 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7.3% stake in Geron Corporation |
| 02/21/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/02/2020 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.2% stake in TG Therapeutics, Inc. |
| 09/16/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.1% stake in Audentes Therapeutics, Inc. |
| 09/16/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.7% stake in Abeona Therapeutics Inc. |
| 09/16/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.3% stake in Zogenix Inc. |
| 08/09/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.3% stake in Zymeworks Inc. |
| 08/05/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/14/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.1% stake in Puma Biotechnology, Inc. |
| 01/11/2019 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7% stake in BioCryst Pharmaceuticals Inc. |
| 12/17/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 10% stake in Millendo Therapeutics, Inc. |
| 11/15/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.8% stake in Cytokinetics, Inc. |
| 11/05/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 6.2% stake in Proteostasis Therapeutics, Inc. |
| 10/19/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.1% stake in Five Prime Therapeutics, Inc. |
| 08/13/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 6.8% stake in Menlo Therapeutics Inc. |
| 08/06/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 6.4% stake in Savara Inc. |
| 07/09/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 9.5% stake in Zafgen, Inc. |
| 07/02/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7% stake in Protagonist Therapeutics, Inc. |
| 12/08/2017 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.1% stake in Catalyst Pharmaceuticals, Inc. |
| 08/21/2017 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.9% stake in Kura Oncology, Inc. |
| 06/16/2017 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.2% stake in PTC Therapeutics Inc. |
|
|
|